biostudies-literatureCusatis RNational Institute of Allergy and Infectious DiseasesNIEHS NIH HHSNational Cancer InstituteNCI NIH HHSHealth Resources and Services AdministrationNational Heart Lung and Blood InstituteOffice of Naval Research917.e1-917.e12https://www.ebi.ac.uk/biostudies/studies/S-EPMC11587342biostudies-literatureUnknown30(9)The Center for International Blood and Marrow Transplant Research (CIBMTR) prepares an annual set of summary slides to summarize the trends in transplantation and cellular therapies. For the first time in the 2023 summary slides, the CIBMTR incorporated data for patients receiving chimeric antigen receptor T cell (CAR-T) infusions. In addition, data on patient-reported outcomes (PROs) are included. This report aims to update the annual trends in US hematopoietic cell transplantation (HCT) activity and incorporate data on the use of CAR-T therapies. A second aim is to present and describe the development, implementation, and current status of PRO data collection. In August 2020, the CIBMTR launched the Protocol for Collection of Patient-Reported Outcomes Data (CIBMTR PRO Protocol). The CIBMTransplantation and cellular therapyCurrent Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry.PMC1158734227398C0011U24 CA07651827305C001127307C0011Rizzo DPhelan RJaglowski SDevine SMBolon YTYusuf RBroglie LKaur MAkinola IBupp CHengen MAkhtar OKuxhausen MSpellman SRZhan KLitovich CSteinert PKapfhammer MPage KMFeng ZLee SJChen MSaber WTuschl EMattila DCusatis RFlynn KEPasquini MCAuletta JJShaw BEHamadani MStefanski HEAllbee-Johnson MBloomquist JMoskop AfalseCurrent Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry.The Center for International Blood and Marrow Transplant Research (CIBMTR) prepares an annual set of summary slides to summarize the trends in transplantation and cellular therapies. For the first time in the 2023 summary slides, the CIBMTR incorporated data for patients receiving chimeric antigen receptor T cell (CAR-T) infusions. In addition, data on patient-reported outcomes (PROs) are included. This report aims to update the annual trends in US hematopoietic cell transplantation (HCT) activity and incorporate data on the use of CAR-T therapies. A second aim is to present and describe the development, implementation, and current status of PRO data collection. In August 2020, the CIBMTR launched the Protocol for Collection of Patient-Reported Outcomes Data (CIBMTR PRO Protocol). The CIBM2024-01-01T00:00:00Z2024 Sep2026-05-28T20:26:17.466Z2026-04-08T03:02:50.053ZS-EPMC115873423894415310.1016/j.jtct.2024.06.021